Sandeep Sheth Selected Research

Sandeep Sheth Research Topics

Disease

14	Neoplasms (Cancer) 01/2023 - 01/2010
13	Hearing Loss (Hearing Impairment) 01/2023 - 03/2011
11	Ototoxicity 01/2023 - 03/2011
7	Inflammation (Inflammations) 01/2023 - 03/2011
3	Neoplasm Metastasis (Metastasis) 03/2020 - 01/2012
3	Prostatic Neoplasms (Prostate Cancer) 01/2017 - 01/2012
2	Pain (Aches) 01/2022 - 01/2019
2	Peripheral Nervous System Diseases (PNS Diseases) 11/2019 - 01/2019
1	Testicular Neoplasms (Testicular Cancer) 01/2023
1	Communicable Diseases (Infectious Diseases) 01/2023
1	Necrosis 01/2023
1	Brain Diseases (Brain Disorder) 01/2023
1	Deafness (Deaf Mutism) 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 12/2020
1	Peritoneal Diseases 12/2020
1	Peritoneal Neoplasms 03/2020
1	Hidden Hearing Loss 01/2019
1	Wounds and Injuries (Trauma) 05/2011
1	Infections 05/2011
1	Sensorineural Hearing Loss 05/2011

Drug/Important Bio-Agent (IBA)

12	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 03/2011
6	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 12/2013
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2011
3	Small Interfering RNA (siRNA)IBA 01/2023 - 03/2011
3	Capsaicin (Zostrix)FDA Link 01/2022 - 03/2011
3	Adenosine A1 ReceptorIBA 01/2021 - 04/2016
3	N-(1-methyl-2-phenylethyl)adenosine (S-PIA)IBA 01/2019 - 01/2010
3	NADPH Oxidases (NAD(P)H oxidase)IBA 04/2016 - 03/2011
2	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 04/2016
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2021 - 01/2018
2	CannabinoidsIBA 11/2019 - 01/2017
2	AntioxidantsIBA 01/2018 - 01/2017
2	Protective AgentsIBA 01/2018 - 05/2011
2	ResveratrolIBA 01/2017 - 01/2012
2	PhenylisopropyladenosineIBA 04/2016 - 01/2010
2	SERPIN-B5 (maspin)IBA 12/2013 - 01/2012
2	Androgen Receptors (Androgen Receptor)IBA 12/2013 - 01/2012
2	MicroRNAs (MicroRNA)IBA 12/2013 - 01/2012
1	SB 225002IBA 01/2023
1	CaspasesIBA 01/2023
1	Interleukin-8B ReceptorsIBA 01/2023
1	Chemokine CXCL1IBA 01/2023
1	CarbonIBA 01/2023
1	Glutamic Acid (Glutamate)FDA Link 01/2023
1	CXC ChemokinesIBA 01/2023
1	CationsIBA 01/2022
1	LigandsIBA 01/2021
1	GTP-Binding Proteins (G-Protein)IBA 01/2021
1	PlatinumIBA 12/2020
1	Transcription Factors (Transcription Factor)IBA 11/2019
1	Caffeine (No Doz)FDA LinkGeneric 01/2019
1	CalciumIBA 01/2019
1	Etanercept (Enbrel)FDA Link 01/2019
1	iodopravadoline (AM 630)IBA 01/2018
1	Adenosine Triphosphatases (ATPase)IBA 01/2018
1	EndocannabinoidsIBA 01/2018
1	Apoptosis Regulatory ProteinsIBA 01/2017
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2017
1	CytokinesIBA 01/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2017
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2017
1	Long Noncoding RNAIBA 01/2017
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2017
1	Investigational DrugsIBA 02/2015
1	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 12/2013
1	OligonucleotidesIBA 01/2012
1	RNA (Ribonucleic Acid)IBA 01/2012
1	AminoglycosidesIBA 05/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2011
1	Messenger RNA (mRNA)IBA 01/2010

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 01/2023 - 05/2011
3	Oral Administration 11/2019 - 01/2012
3	Injections 04/2016 - 03/2011
2	Cytoreduction Surgical Procedures 12/2020 - 03/2020
1	Hyperthermic Intraperitoneal Chemotherapy 03/2020
1	Therapeutics 05/2011